APA (7th ed.) Citation

Dickinson, M., Herbert, K., Sardjono, C., Le, T., Link, E., Zannino, D., . . . Prince, H. (2013). P-276 High doses of eltrombopag are well-tolerated in conjunction with azacitidine and demonstrate encouraging activity in patients with MDS and AML. Leukemia Research, 37, S147. https://doi.org/10.1016/S0145-2126(13)70323-0

Chicago Style (17th ed.) Citation

Dickinson, M., et al. "P-276 High Doses of Eltrombopag Are Well-tolerated in Conjunction with Azacitidine and Demonstrate Encouraging Activity in Patients with MDS and AML." Leukemia Research 37 (2013): S147. https://doi.org/10.1016/S0145-2126(13)70323-0.

MLA (9th ed.) Citation

Dickinson, M., et al. "P-276 High Doses of Eltrombopag Are Well-tolerated in Conjunction with Azacitidine and Demonstrate Encouraging Activity in Patients with MDS and AML." Leukemia Research, vol. 37, 2013, p. S147, https://doi.org/10.1016/S0145-2126(13)70323-0.